| Literature DB >> 23594221 |
Julie S Jacobsen1, Dennis B Nielsen, Henrik Sørensen, Kjeld Søballe, Inger Mechlenburg.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2013 PMID: 23594221 PMCID: PMC3715823 DOI: 10.3109/17453674.2013.792030
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure.32 patients with hip dysplasia were included from the Division of Hip Surgery at the Department of Orthopedics at Aarhus University Hospital in Denmark from March 1st 2011 to December 1st 2011.
Baseline characteristics of the patients and healthy controls
| Outcomes | Patients | Controls | p-value |
|---|---|---|---|
| Women, n | 26 | 26 | – |
| Age, years (range) | 34 (18–53) | 33 (18–54) | – |
| Limb dominance, right n | 29 | 31 | 0.6 |
| BMI (range) | 22 (15–29) | 22 (16–31) | 0.7 |
| Bilateral/unilateral n | 24/8 | – | – |
| Congenital hip dislocation, n | 4 | – | – |
| Duration of pain 0.0–5.0 years, n | 19 | – | – |
| Duration of pain 5.1–10.0 years, n | 9 | – | – |
| Duration of pain > 10 years, n | 4 | – | – |
| Non-prescription analgesia, n | 6 | – | – |
| Prescription analgesia, n | 8 | – | – |
| Osteoarthritis grade 0/grade 1, n | 26/6 | – | – |
| CE angle preoperatively (range) | 18 (4–22) | – | – |
| AI angle preoperatively (range) | 14 (10–22) | – | – |
| HAGOS pain, 0–100 | 49 (20–95) | 100 (85–100) | < 0.001 |
| HAGOS symptoms, 0–100 | 46 (21–96) | 96 (79–100) | < 0.001 |
| HAGOS ADL, 0–100 | 58 (5–100) | 100 (85–100) | < 0.001 |
| HAGOS sport/recreation, 0–100 | 36 (3–91) | 100 (84–100) | < 0.001 |
| HAGOS participation, 0–100 | 25 (0–100) | 100 (50–100) | < 0.001 |
| HAGOS quality of life, 0–100 | 38 (0–80) | 100 (75–100) | < 0.001 |
Baseline characteristics are presented as median values (range) and as numbers for the patients and the healthy controls. Differences between the groups were tested with Wilcoxon signed-rank test and Fisher’s exact test.
BMI: body mass index; HAGOS: Copenhagen Hip and Groin Outcome Score; ADL: activities of daily living; CE (center-edge); AI: Tönnis’ acetabular index.
Peak joint angles in patients and healthy controls
| Peak | Patients | Controls | Difference (95% CI) | p-value |
|---|---|---|---|---|
| (n = 32) | (n = 32) | |||
|
| ||||
| Ankle | ||||
| A1 | –8.9 (2.1) | –9.6 (2.4) | –0.7 (–1.8 to 0.4) | 0.2 |
| A2 | 8.8 (3.5) | 7.3 (2.8) | –1.5 (–3.1 to 0.1) | 0.07 |
| Knee | ||||
| K1 | –4.1 (3.8) | –4.5 (5.1) | –0.4 (–2.7 to 1.8) | 0.7 |
| K2 | –16 (3.7) | –18 (5.5) | –1.6 (–3.9 to 0.8) | 0.2 |
| K3 | –5.5 (4.3) | –3.0 (4.4) | 2.5 (0.3 to 4.7) | 0.03 |
| Hip | ||||
| H1 | –10 (4.8) | –13 (4.5) | –2.7 (–5.1 to –0.4) | 0.02 |
|
| ||||
| Ankle | ||||
| A1 | 1.2 (5.5) | 2.2 (3.8) | 0.2 (–2.2 to 2.9) | 0.9 |
| A2 | 20 (4.5) | 21 (3.8) | 1.4 (–0.7 to 3.5) | 0.2 |
| Knee | ||||
| K1 | –13 (6.2) | –15(6.6) | –2.0 (–5.2 to 1.2) | 0.2 |
| K2 | –39 (7.6) | –42 (5.8) | –2.7 (–6.0 to 0.7) | 0.1 |
| K3 | –16 (6.1) | -15 (5.6) | 1.3 (–1.7 to 4.2) | 0.4 |
| Hip | ||||
| H1 | –4.0 (5.1) | –5.6 (3.9) | –1.6 (–3.8 to 0.7) | 0.2 |
Values are mean (SD).
Peak net joint moments in patients and healthy controls
| Peak | Patients | Controls | Difference (95% CI) | p-value |
|---|---|---|---|---|
| (n = 32) | (n = 32) | |||
|
| ||||
| Ankle | ||||
| MA1 | 0.18 (0.05) | 0.20 (0.05) | 0.01 (–0.01 to 0.04) | 0.3 |
| MA2 | –1.48 (0.17) | –1.56 (0.17) | –0.07 (–0.16 to 0.01) | 0.08 |
| Knee | ||||
| MK1 | –0.42 (0.17) | –0.46 (0.11) | –0.04 (–0.11 to 0.03) | 0.2 |
| MK2 | 0.36 (0.17) | 0.46 (0.19) | 0.10 (0.01 to 0.19) | 0.04 |
| MK3 | –0.42 (0.17) | –0.54 (0.14) | –0.12 (–0.20 to –0.04) | 0.003 |
| MK4 | 0.21 (0.05) | 0.26 (0.13) | 0.04 (0.01 to 0.09) | 0.08 |
| Hip | ||||
| MH1 | –1.08 (0.34) | –1.19 (0.20) | –0.11 (–0.25 to 0.03) | 0.1 |
| MH2 | 0.57 (0.13) | 0.70 (0.22) | 0.13 (0.04 to 0.22) | 0.008 |
|
| ||||
| Ankle | ||||
| MA1 | 0.15 (0.16) | 0.17 (0.12) | 0.02 (–0.05 to 0.09) | 0.6 |
| MA2 | –2.27 (0.45) | –2.32 (0.41) | –0.04 (–0.26 to 0.17) | 0.7 |
| Knee | ||||
| MK1 | –0.50 (0.20) | –0.49 (0.18) | –0.01 (–0.09 to 0.10) | 0.9 |
| MK2 | 1.64 (0.48) | 1.87 (0.42) | 0.23 (0.01 to 0.46) | 0.04 |
| MK3 | –0.29 (0.29) | –0.20 (0.15) | 0.09 (–0.03 to 0.20) | 0.2 |
| MK4 | 1.29 (0.49) | 1.58 (0.41) | 0.29 (0.07 to 0.52) | 0.01 |
| Hip | ||||
| MH1 | –1.57 (0.46) | –1.74 (0.42) | –0.17 (–0.39 to 0.05) | 0.1 |
| MH2 | 0.65 (0.42) | 0.85 (0.30) | 0.20 (0.01 to 0.38) | 0.04 |
Values are mean (SD).
Correlations between the mechanical outcomes and HAGOS
| HAGOS pain | HAGOS sport/recreation | |||
|---|---|---|---|---|
| Baseline | Spearman’s rho | p-value | Spearman’s rho | p-value |
| H1 walking | –0.30 | 0.02 | –0.29 | 0.02 |
| MH2 walking | 0.34 | 0.007 | 0.34 | 0.007 |
| H1 running | –0.17 | 0.2 | –0.15 | 0.3 |
| MH2 running | 0.23 | 0.07 | 0.26 | 0.04 |
Correlations between the peak hip extension angle (H1) and the HAGOS subscales pain and sport/recreation. Also, correlations between the peak net joint moment of hip flexion (MH2) and the HAGOS subscales pain and sport/recreation.